Results 121 to 130 of about 7,967 (189)

Case Report: Progressive interstitial lung disease secondary to Sjögren's disease in a patient with inclusion body myositis complicated by dysphagia-a multidisciplinary approach and therapeutic challenges. [PDF]

Front Med (Lausanne)
Cocchiara E, Cozzini F, Chiapparoli I, Falco F, Bajocchi G, Salvarani C, Manfredi A.   +6 more
europepmc   +1 more source

Inclusion Body Myositis: A case report on navigating diagnostic challenges. [PDF]

Sultan Qaboos Univ Med J
Al Sharji M, Al Busaidi S, Al Jahdhami S, Jawa Z, Farhan H, Al Alawi AM.   +5 more
europepmc   +1 more source

A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis. [PDF]

Rheumatology (Oxford)
Naddaf E, Skolka MP, Prokop L, Dimachkie MM, Hogrel JY, Benveniste O, Wang Z, Mandrekar J, West CP, Murad MH.   +9 more
europepmc   +1 more source

Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body Myositis. [PDF]

J Cachexia Sarcopenia Muscle
de Vries GM, Asselbergh B, Monticelli A, De Jonghe P, Maudsley S, Van Den Bergh PYK, Bigot A, De Bleecker JL, Ermanoska B, De Ridder W, Baets J.   +10 more
europepmc   +1 more source

Inclusion body myositis and immunosenescence: current evidence and future perspectives. [PDF]

Rheumatology (Oxford)
Allameen NA, Salam S, Reddy V, Machado PM.   +3 more
europepmc   +1 more source

Mitochondria-centred metabolomic map of inclusion body myositis: sex-specific alterations in central carbon metabolism. [PDF]

Ann Rheum Dis
Naddaf E, Shammas I, Dasari S, Petterson XT, Springer W, Trushina E, Lanza IR.   +6 more
europepmc   +1 more source

Reply to Owais Et al. Concerns Regarding "Small Fiber Morphology and Function in Inclusion Body Myositis-A Multimodal Assessment Including Confocal Corneal Microscopy". [PDF]

Eur J Neurol
Sturm D, Güttsches AK, Vorgerd M, Schwenkreis P, Westermann A, Greiner T, Vollert J, Eitner L, Maier C, Forsting J, Enax-Krumova E.   +10 more
europepmc   +1 more source

Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review. [PDF]

RMD Open
Santos EJF, Farisogullari B, Yapp N, Townsley H, Sousa P, Machado PM.   +5 more
europepmc   +1 more source

Altered Transcriptome Signature in Primary Human Myotubes Exposed to Inclusion Body Myositis Serum: A Pilot Case Comparison of Anti-cN1A Positive and Negative Sera. [PDF]

Muscles
Slater N, Chopra A, Ram R, Adams A, Mastaglia FL, Needham M, Coudert JD.   +6 more
europepmc   +1 more source